Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
OraSure Technologies Stock Quote

OraSure Technologies (NASDAQ: OSUR)

$5.26
(-2.7%)
-$0.14
Price as of April 16, 2024, 1:01 p.m. ET

OraSure Technologies Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
OSUR -19.85% -43.35% -10.74% +28%
S&P +22.34% +74.52% +11.78% +1,380%

OraSure Technologies Company Info

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

News & Analysis

The Fool has written over 100 articles on OraSure Technologies.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.